AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PHR
  4. [Form 4] Phreesia, Inc. Insider Trading Activity

[Form 4] Phreesia, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Phreesia, Inc. (PHR) reported an insider sale by Chief Financial Officer Balaji Gandhi under a Rule 10b5-1 trading plan. On 08/25/2025 Mr. Gandhi sold 9,583 shares of common stock in multiple transactions at a weighted average price of $30.0063 per share, with individual prices ranging from $30.00 to $30.81. After the sale he beneficially owned 97,078 shares. The filing discloses the 10b5-1 plan adoption date of September 17, 2024 and states the seller will provide detailed per-price quantities on request.

Phreesia, Inc. (PHR) ha comunicato una vendita da parte dell'amministratore finanziario (CFO) Balaji Gandhi nell'ambito di un piano di negoziazione Rule 10b5-1. Il 25/08/2025 il Sig. Gandhi ha venduto 9.583 azioni ordinarie in pi霉 transazioni a un prezzo medio ponderato di 30,0063 USD per azione, con prezzi unitari compresi tra 30,00 e 30,81 USD. Dopo la vendita risultava titolare effettivo di 97.078 azioni. La comunicazione indica che il piano 10b5-1 猫 stato adottato il 17 settembre 2024 e che il venditore fornir脿, su richiesta, i dettagli delle quantit脿 per ogni prezzo.

Phreesia, Inc. (PHR) inform贸 una venta de un insider realizada por el director financiero (CFO) Balaji Gandhi bajo un plan de negociaci贸n Rule 10b5-1. El 25/08/2025 el Sr. Gandhi vendi贸 9.583 acciones ordinarias en varias transacciones a un precio medio ponderado de 30,0063 USD por acci贸n, con precios individuales entre 30,00 y 30,81 USD. Tras la operaci贸n pose铆a de forma beneficiosa 97.078 acciones. El documento revela que el plan 10b5-1 fue adoptado el 17 de septiembre de 2024 y que el vendedor facilitar谩, a solicitud, las cantidades por cada precio.

Phreesia, Inc.(PHR)電� 斓滉碃鞛毂呾瀯鞛�(CFO) 氚滊澕歆� 臧勲敂(Balaji Gandhi)鞚� 雮措秬鞛� 毵る弰 靷嫟鞚� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 瓿奠嫓頄堨姷雼堧嫟. 2025-08-25鞐� 臧勲敂 鞌姅 氤错喌欤� 9,583欤茧ゼ 鞐煬 瓯挫潣 瓯半灅搿� 欤茧嫻 臧�欷戫弶攴犼皜瓴� 30.0063雼煬鞐� 毵る弰頄堨溂氅�, 臧滊硠 瓯半灅 臧�瓴╈潃 30.00雼煬鞐愳劀 30.81雼煬 靷澊鞓�鞀惦媹雼�. 毵る弰 頉� 臧勲敂 鞌姅 97,078欤茧ゼ 鞁れ 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 10b5-1 瓿勴殟 毂勴儩鞚检澊 2024雲� 9鞗� 17鞚茧 旮办灛霅橃柎 鞛堦碃, 韺愲Г鞛愲姅 鞖旍箔 鞁� 臧�瓴╇硠 靾橂焿鞚� 靸侅劯頌� 鞝滉车頃橁矤雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.

Phreesia, Inc. (PHR) a d茅clar茅 une cession d'initi茅 r茅alis茅e par son directeur financier (CFO), Balaji Gandhi, dans le cadre d'un plan de n茅gociation Rule 10b5-1. Le 25/08/2025, M. Gandhi a vendu 9 583 actions ordinaires lors de plusieurs transactions 脿 un prix moyen pond茅r茅 de 30,0063 USD par action, les prix unitaires variant entre 30,00 et 30,81 USD. Apr猫s la vente, il d茅tenait directement 97 078 actions. Le d茅p么t pr茅cise que le plan 10b5-1 a 茅t茅 adopt茅 le 17 septembre 2024 et indique que le vendeur fournira, sur demande, les quantit茅s d茅taill茅es par prix.

Phreesia, Inc. (PHR) meldete einen Insider-Verkauf durch Chief Financial Officer Balaji Gandhi im Rahmen eines Rule-10b5-1-Handelsplans. Am 25.08.2025 verkaufte Herr Gandhi insgesamt 9.583 Stammaktien in mehreren Transaktionen zu einem gewichteten Durchschnittspreis von 30,0063 USD je Aktie, mit Einzelpreisen zwischen 30,00 und 30,81 USD. Nach dem Verkauf hielt er wirtschaftlich 97.078 Aktien. Die Einreichung gibt das Datum der Annahme des 10b5-1-Plans mit dem 17. September 2024 an und vermerkt, dass der Verk盲ufer auf Anfrage detaillierte Mengenangaben zu den einzelnen Preisen bereitstellt.

Positive
  • Sale executed under a documented Rule 10b5-1 plan, adopted 09/17/2024, which provides an affirmative defense to insider trading claims
  • Clear disclosure of transaction details including weighted average price and price range, and an offer to provide per-price quantities upon request
  • Form 4 properly completed and signed (attorney-in-fact signature present), supporting regulatory compliance
Negative
  • CFO reduced direct holdings by 9,583 shares, lowering beneficial ownership to 97,078 shares
  • Sale proceeds potentially dilute perceived insider ownership which some investors monitor as a sentiment indicator

Insights

TL;DR: Routine insider sale under a pre-established 10b5-1 plan; transaction appears procedural rather than indicating new company-specific news.

The reported sale of 9,583 shares at a weighted average of $30.0063 reduces the CFO's beneficial holdings to 97,078 shares. The use of a 10b5-1 plan (adopted 09/17/2024) signals these trades were pre-authorized and likely part of a scheduled liquidity plan rather than opportunistic timing by management. The filing is properly executed and includes an undertakings to disclose per-price quantities on request, supporting transparency.

TL;DR: Disclosure aligns with best practices: sale executed under a documented 10b5-1 plan and properly reported on Form 4.

The Form 4 shows required elements: reporting person details, relationship (CFO), transaction date (08/25/2025), and signature by an attorney-in-fact. The explicit note about price ranges and willingness to provide per-trade details enhances disclosure quality. No amendment flag or additional governance events are present in the filing.

Phreesia, Inc. (PHR) ha comunicato una vendita da parte dell'amministratore finanziario (CFO) Balaji Gandhi nell'ambito di un piano di negoziazione Rule 10b5-1. Il 25/08/2025 il Sig. Gandhi ha venduto 9.583 azioni ordinarie in pi霉 transazioni a un prezzo medio ponderato di 30,0063 USD per azione, con prezzi unitari compresi tra 30,00 e 30,81 USD. Dopo la vendita risultava titolare effettivo di 97.078 azioni. La comunicazione indica che il piano 10b5-1 猫 stato adottato il 17 settembre 2024 e che il venditore fornir脿, su richiesta, i dettagli delle quantit脿 per ogni prezzo.

Phreesia, Inc. (PHR) inform贸 una venta de un insider realizada por el director financiero (CFO) Balaji Gandhi bajo un plan de negociaci贸n Rule 10b5-1. El 25/08/2025 el Sr. Gandhi vendi贸 9.583 acciones ordinarias en varias transacciones a un precio medio ponderado de 30,0063 USD por acci贸n, con precios individuales entre 30,00 y 30,81 USD. Tras la operaci贸n pose铆a de forma beneficiosa 97.078 acciones. El documento revela que el plan 10b5-1 fue adoptado el 17 de septiembre de 2024 y que el vendedor facilitar谩, a solicitud, las cantidades por cada precio.

Phreesia, Inc.(PHR)電� 斓滉碃鞛毂呾瀯鞛�(CFO) 氚滊澕歆� 臧勲敂(Balaji Gandhi)鞚� 雮措秬鞛� 毵る弰 靷嫟鞚� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 瓿奠嫓頄堨姷雼堧嫟. 2025-08-25鞐� 臧勲敂 鞌姅 氤错喌欤� 9,583欤茧ゼ 鞐煬 瓯挫潣 瓯半灅搿� 欤茧嫻 臧�欷戫弶攴犼皜瓴� 30.0063雼煬鞐� 毵る弰頄堨溂氅�, 臧滊硠 瓯半灅 臧�瓴╈潃 30.00雼煬鞐愳劀 30.81雼煬 靷澊鞓�鞀惦媹雼�. 毵る弰 頉� 臧勲敂 鞌姅 97,078欤茧ゼ 鞁れ 氤挫湢頃橁碃 鞛堨棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 10b5-1 瓿勴殟 毂勴儩鞚检澊 2024雲� 9鞗� 17鞚茧 旮办灛霅橃柎 鞛堦碃, 韺愲Г鞛愲姅 鞖旍箔 鞁� 臧�瓴╇硠 靾橂焿鞚� 靸侅劯頌� 鞝滉车頃橁矤雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.

Phreesia, Inc. (PHR) a d茅clar茅 une cession d'initi茅 r茅alis茅e par son directeur financier (CFO), Balaji Gandhi, dans le cadre d'un plan de n茅gociation Rule 10b5-1. Le 25/08/2025, M. Gandhi a vendu 9 583 actions ordinaires lors de plusieurs transactions 脿 un prix moyen pond茅r茅 de 30,0063 USD par action, les prix unitaires variant entre 30,00 et 30,81 USD. Apr猫s la vente, il d茅tenait directement 97 078 actions. Le d茅p么t pr茅cise que le plan 10b5-1 a 茅t茅 adopt茅 le 17 septembre 2024 et indique que le vendeur fournira, sur demande, les quantit茅s d茅taill茅es par prix.

Phreesia, Inc. (PHR) meldete einen Insider-Verkauf durch Chief Financial Officer Balaji Gandhi im Rahmen eines Rule-10b5-1-Handelsplans. Am 25.08.2025 verkaufte Herr Gandhi insgesamt 9.583 Stammaktien in mehreren Transaktionen zu einem gewichteten Durchschnittspreis von 30,0063 USD je Aktie, mit Einzelpreisen zwischen 30,00 und 30,81 USD. Nach dem Verkauf hielt er wirtschaftlich 97.078 Aktien. Die Einreichung gibt das Datum der Annahme des 10b5-1-Plans mit dem 17. September 2024 an und vermerkt, dass der Verk盲ufer auf Anfrage detaillierte Mengenangaben zu den einzelnen Preisen bereitstellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gandhi Balaji
(Last) (First) (Middle)
C/O PHREESIA
1521 CONCORD PIKE, SUITE 301 PMB 221
(Street)
WILMINGTON DE 19803
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Phreesia, Inc. [ PHR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 S(1) 9,583 D $30.0063(2) 97,078 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.81 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Allison Hoffman, as Attorney-in-Fact for Balaji Gandhi 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Phreesia CFO Balaji Gandhi sell on 08/25/2025 (PHR)?

The CFO sold 9,583 shares of Phreesia common stock in multiple transactions at a weighted average price of $30.0063 per share.

Was the sale by Balaji Gandhi pre-planned under a 10b5-1 plan?

Yes. The Form 4 states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 17, 2024.

How many shares does Balaji Gandhi beneficially own after the reported transaction?

After the sale, the reporting person beneficially owned 97,078 shares.

What price range were the shares sold at in the Form 4?

The filing reports a weighted average of $30.0063 and indicates sales occurred at prices ranging from $30.00 to $30.81 per share.

Who signed the Form 4 for the reporting person?

The Form 4 was signed on behalf of Balaji Gandhi by Allison Hoffman, as Attorney-in-Fact, dated 08/27/2025.
Stock PHR logo
Phreesia

NYSE:PHR

PHR Rankings

#2139 Ranked by Market Cap
N/A Ranked by Dividends

PHR Latest News

Sep 4, 2025
Phreesia Announces Second Quarter Fiscal 2026 Results
Sep 4, 2025
Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions
Sep 2, 2025
Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare
Aug 21, 2025
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
Aug 12, 2025
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling

PHR Latest SEC Filings

Sep 5, 2025
[10-Q] Phreesia, Inc. Quarterly Earnings Report
Sep 4, 2025
[8-K] Phreesia, Inc. Reports Material Event
Aug 29, 2025
[Form 4] Phreesia, Inc. Insider Trading Activity
Aug 29, 2025
[Form 4] Phreesia, Inc. Insider Trading Activity
Aug 28, 2025
[144] Phreesia, Inc. SEC Filing

PHR Stock Data

1.86B
56.77M
4.33%
100.74%
4.88%
Health Information Services
Services-business Services, Nec
United States
WILMINGTON